173943-99-2

Basic information

• Product Name: 5-Methylspiro[1,3-dihydroisobenzofuran-3,4'-piperidine] hydrochloride
• Synonyms: 5-Methylspiro[1,3-dihydroisobenzofuran-3,4'-piperidine] hydrochloride;6-Methyl-3H-spiro[isobenzofuran-1,4'-piperidine] hydrochloride;5-Methyl-3H-spiro[2-benzofuran-1,4'-piperidine]hydrochloride;6-Methyl-3H-spiro[2-benzofuran-1,4'-piperidine] hydrochloride
• CAS NO: 173943-99-2
• Molecular Formula: C13H18ClNO
• Molecular Weight: 239.74112
• EINECS: -0
• Mol File: 173943-99-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Methylspiro[1,3-dihydroisobenzofuran-3,4'-piperidine] hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Methylspiro[1,3-dihydroisobenzofuran-3,4'-piperidine] hydrochloride(173943-99-2)
• EPA Substance Registry System: 5-Methylspiro[1,3-dihydroisobenzofuran-3,4'-piperidine] hydrochloride(173943-99-2)

Safety Data

• Hazardous Substances Data: 173943-99-2(Hazardous Substances Data)

Relevant articles and documents

SPIROCYCLIC PIPERIDINES AS MCH1 ANTAGONISTS AND USES THEREOF

This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject=s depression and/or anxiety. This invention further provides a method of treating a subject suffering from a urinary disorder.